BioCentury
ARTICLE | Clinical News

CDA: Phase III started

July 31, 2006 7:00 AM UTC

GSK started a double-blind, African Phase III trial in 900 patients to compare CDA to GSK's Lapdap, a combination of chlorproguanil hydrochloride and dapsone. GSK is developing CDA with the Medicines ...